Back to Top Skip to main content

Possible cause for severe eczema has been found

Some patients living with severe eczema – a possible disqualifying factor for military service – have been found to have mutations on a gene called CARD11. Identified as a possible cause for the condition, the discovery can lead to exciting possibilities for advancements, according to the researchers. Some patients living with severe eczema – a possible disqualifying factor for military service – have been found to have mutations on a gene called CARD11. Identified as a possible cause for the condition, the discovery can lead to exciting possibilities for advancements, according to the researchers.

Recommended Content:

Conditions and Treatments | Innovation | Warrior Care

For more than 17 million people in the United States living with severe eczema – a condition that results in dry, itchy rashes and disqualifies many from military service – the mystery behind its cause may be all too familiar. Thanks to researchers at the Uniformed Services University of Health Sciences and National Institutes of Health, certain patients may understand more about their condition.

“Studying these … disorders, especially when we can define the disease based on a single mutation, is incredibly informative because you can learn a lot,” said Andrew Snow, assistant professor in the department of pharmacology and molecular therapeutics at USU, and senior co-author of a study recently published in the journal Nature Genetics.

Researchers at the Uniformed Services University of Health Sciences and National Institutes of Health identified mutations in a gene known as CARD11 as one underlying cause for severe eczema. (U.S. Air Force photo by Senior Airman Ashlin Federick)Researchers at the Uniformed Services University of Health Sciences and National Institutes of Health identified mutations in a gene known as CARD11 as one underlying cause for severe eczema. (U.S. Air Force photo by Senior Airman Ashlin Federick)

In this study, mutations in a gene known as CARD11 were identified as one underlying cause for severe eczema. The discovery led the researchers to ask whether excess glutamine can help correct some of the allergy-related defects in patients’ immune cells. The testing was done with T cells, known as the conductors of the body’s immune response against infections, from one patient in a lab, and the results were promising. Additional work with the NIH to study whether symptoms for patients with similar mutations improve with glutamine supplements – a readily available product in stores – is likely, said Snow.

Severe eczema can run in families, which suggests a genetic cause, said Snow. One by one, Snow and NIH allergist Dr. Joshua Milner received referrals for patients who had mutations in the same gene – totaling eight patients from four different families.

“However, such treatments are not a cure for the cause of the disease, particularly if it’s a genetic cause,” said Snow.

During the study, researchers discovered these CARD11 mutations can prevent T cells  from being able to do their jobs normally. The mutations prevent the cells from taking in enough glutamine, which is needed for T cells to maintain their proper function. This may help explain why some patients with severe eczema have a history of pneumonia, warts, and other types of lung and skin infections, said Snow.

While a mutation in the CARD11 gene is only one possible cause for severe eczema, its discovery can influence new therapies. Current treatments, including over-the-counter and prescription pills or creams, focus on bringing down the inflammation and relieving the itching.

Jeffrey Stinson, a former USU graduate student in Snow’s laboratory, who is currently at the National Institute of Standards and Technology and co-author on the study, said the possibility of having something so easily accessible as a targeted form of treatment would be an incredible achievement for those living with severe eczema and other allergic symptoms.

“This genetic condition is considered rare, but it’s important to acknowledge the impact that findings from small, basic research studies like this can have in the medical field,” said Stinson, stressing that the research would not be possible without the time and participation of the families who volunteer. “Thanks to their dedication, we have new and exciting possibilities for advancement before us.” 

You also may be interested in...

Waiver of Restrictive Licensure and Privileging Procedures to Facilitate the Expansion of Telemedicine Services in the Military Health System 12-010

Policy

In order to facilitate the expansion of telemedicine services in the Military Health System, this memorandum waives selective provisions of Department of Defense 602S.13-R, "Clinical Quality Assurance in the Military Health System," June 11 , 2004. This waiver is conditioned on the specific provisions of this memorandum, and shall remain in effect, unless modified or revoked, until the cancellation and reissuance of DoD 602S.13-R, or the issuance of a Department of Defense Instruction for or including telemedicine.

DCoE Concussion Management Algorithm Cards

Form/Template
10/8/2012

Combat Medic/Corpsman Algorithm Card to diagnose a concussion in a deployed setting

Recommended Content:

Conditions and Treatments | Physical Disability | Traumatic Brain Injury | Health Readiness

DoD Instruction Number 6490.11: DoD Policy Guidance for Management of Mild Traumatic Brain Injury/Concussion in the Deployed Setting

Policy

This instruction establishes policy, assigns responsibilities, and provides procedures on the management of mild traumatic brain injury (mTBI), also known as concussion, in the deployed setting.

Planning for the Reform of the Governance of the Military Health System

Policy
  • Identification #: N/A
  • Date: 3/2/2012
  • Type: Guidelines
  • Topics: Innovation

Indications and Conditions for In-Theater Post-Injury Neurocognitive Assessment Tool (NCAT) Testing

Report
5/31/2011

In accordance with Section 1673 of the NDAA HR 4986, signed into law in January of 2008, the Secretary of Defense was instructed to establish a protocol for the pre-deployment assessment and documentation of the cognitive functioning of Service Members deployed outside the United States.

Recommended Content:

Conditions and Treatments | Health Readiness | Traumatic Brain Injury | Physical Disability

DoD Instruction 1300.24: Recovery Coordination Program (RCP)

Policy

This instruction establishes policy, assigns responsibilities, and prescribes uniform guidelines, procedures, and standards for improvements to the care, management, and transition of recovering Service members (RSMs) across the Military Departments.

  • Identification #: DoD Instruction 1300.24
  • Date: 12/1/2009
  • Type: Instructions
  • Topics: Warrior Care
<< < ... 6 7 8 9 > >> 
Showing results 121 - 126 Page 9 of 9

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.